DRW Securities’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$736K Sell
800
-3,700
-82% -$3.75M 0.01% 436
2025
Q4
$4.84M Sell
4,500
-2,700
-38% -$2.58M 0.13% 122
2025
Q3
$5.49M Buy
7,200
+2,900
+67% +$2.16M 0.1% 116
2025
Q2
$3.35M Sell
4,300
-21,300
-83% -$16.6M 0.08% 143
2025
Q1
$21.1M Buy
+25,600
New +$21.3M 0.59% 33
2024
Q3
Sell
-500
Closed -$456K 652
2024
Q2
$456K Sell
500
-200
-29% -$160K 0.02% 337
2024
Q1
$545K Buy
+700
New +$498K 0.01% 220

Other funds holding LLY

DRW Securities's LLY Position: Q1 2026 in Review

DRW Securities reduced its Eli Lilly (LLY) stake by 91% in Q1 2026, selling an estimated $4.77M and leaving 459 shares worth $422K. The position accounts for 0.01% of the portfolio, ranked #698.

DRW Securities first reported a position in LLY in Q4 2017 and has held it in 20 quarters since. The position peaked at $9.1M in Q1 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • DRW Securities held 459 shares of Eli Lilly worth $422K as of Q1 2026.
  • DRW Securities sold 4,707 Eli Lilly shares in Q1 2026, an estimated $4.77M.
  • Eli Lilly made up 0.01% of DRW Securities's portfolio in Q1 2026, its #698 holding.
  • DRW Securities first reported a position in Eli Lilly in Q4 2017 and has held it in 20 quarters since.
  • DRW Securities's Eli Lilly position peaked at $9.1M in Q1 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.